CN103848831B - 一种多索茶碱化合物及其药物组合物 - Google Patents
一种多索茶碱化合物及其药物组合物 Download PDFInfo
- Publication number
- CN103848831B CN103848831B CN201410101694.8A CN201410101694A CN103848831B CN 103848831 B CN103848831 B CN 103848831B CN 201410101694 A CN201410101694 A CN 201410101694A CN 103848831 B CN103848831 B CN 103848831B
- Authority
- CN
- China
- Prior art keywords
- doxofylline
- compound
- injection
- leave standstill
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
- C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410101694.8A CN103848831B (zh) | 2014-03-18 | 2014-03-18 | 一种多索茶碱化合物及其药物组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410101694.8A CN103848831B (zh) | 2014-03-18 | 2014-03-18 | 一种多索茶碱化合物及其药物组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103848831A CN103848831A (zh) | 2014-06-11 |
CN103848831B true CN103848831B (zh) | 2015-03-11 |
Family
ID=50856986
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410101694.8A Active CN103848831B (zh) | 2014-03-18 | 2014-03-18 | 一种多索茶碱化合物及其药物组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103848831B (zh) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4187307A (en) * | 1978-10-16 | 1980-02-05 | Abbott Laboratories | Diuretics |
CN1468600A (zh) * | 2002-07-18 | 2004-01-21 | 挺 赵 | 多索茶碱葡萄糖注射液的制备方法 |
CN103145713A (zh) * | 2013-03-26 | 2013-06-12 | 山西普德药业股份有限公司 | 一种多索茶碱结晶化合物及其冻干粉针 |
CN103524503A (zh) * | 2013-10-29 | 2014-01-22 | 天津梅花医药有限公司 | 多索茶碱半水化合物 |
-
2014
- 2014-03-18 CN CN201410101694.8A patent/CN103848831B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4187307A (en) * | 1978-10-16 | 1980-02-05 | Abbott Laboratories | Diuretics |
CN1468600A (zh) * | 2002-07-18 | 2004-01-21 | 挺 赵 | 多索茶碱葡萄糖注射液的制备方法 |
CN103145713A (zh) * | 2013-03-26 | 2013-06-12 | 山西普德药业股份有限公司 | 一种多索茶碱结晶化合物及其冻干粉针 |
CN103524503A (zh) * | 2013-10-29 | 2014-01-22 | 天津梅花医药有限公司 | 多索茶碱半水化合物 |
Also Published As
Publication number | Publication date |
---|---|
CN103848831A (zh) | 2014-06-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101461949B (zh) | 一种小檗碱环糊精包合物、其制剂和制备方法 | |
CN103159769B (zh) | 一种多索茶碱化合物及其药物组合物 | |
CN100457139C (zh) | 一种双黄连注射液的制备方法及其成分检测方法 | |
CN110128356A (zh) | 一种吉非替尼与3-羟基苯甲酸共晶体 | |
CN105524127B (zh) | 一种天麻素化合物及其制剂 | |
CN110934824A (zh) | 能有效溶解奥硝唑或左奥硝唑的溶剂体系及其应用 | |
CN110156700A (zh) | 吉非替尼与水杨酸共晶体 | |
CN103224539B (zh) | 一种天麻素化合物及其药物组合物 | |
CN102391336B (zh) | 一种化合物、其制备方法及用途 | |
CN102127042B (zh) | 一类高异黄酮化合物及制备方法和用途 | |
CN103145713A (zh) | 一种多索茶碱结晶化合物及其冻干粉针 | |
CN103848831B (zh) | 一种多索茶碱化合物及其药物组合物 | |
CN102846704B (zh) | 一种益母草注射液、其制备方法和总生物碱的检测方法 | |
CN105037361A (zh) | 一种多索茶碱化合物及其药物组合物 | |
CN102670670B (zh) | 一种高银杏萜类内酯含量的银杏达莫注射液的制备方法 | |
CN102786573A (zh) | 甘草次酸晶b型物质及制备方法与在药品和保健品中应用 | |
CN1931216B (zh) | 一种由红花与红景天制成的药物组合物 | |
CN102775405B (zh) | 一种高溶解度的多索茶碱化合物 | |
CN103819530B (zh) | 一种甘草酸单铵化合物及含甘草酸单铵的药物组合物 | |
EP2730575B1 (en) | Crystal form i of salt of dipeptidyl peptidase-iv inhibitor and preparation method and use thereof | |
CN101683320A (zh) | 一种盐酸奥普立农注射液及其制备方法 | |
CN103524503B (zh) | 多索茶碱半水化合物 | |
CN104230932A (zh) | 苦参碱衍生物及其制备方法与应用 | |
CN102786574A (zh) | 甘草次酸晶a型物质及制备方法与在药品和保健品中应用 | |
CN101099756B (zh) | 一种治疗肝癌的中药组合物及其制备方法和药物制剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent for invention or patent application | ||
CB02 | Change of applicant information |
Address after: Seven of 276017 Shandong province Linyi city Luozhuang District Applicant after: Shandong Luo Xin Pharmaceutical Group Plc Address before: Seven of 276017 Shandong province Linyi city Luozhuang District Applicant before: SHANDONG LUOXIN PHARMACY STOCK Co., LTD. |
|
COR | Change of bibliographic data |
Free format text: CORRECT: APPLICANT; FROM: SHANDONG LUOXIN PHARMACY STOCK CO., LTD. TO: SHANDONG LUOXIN PHARMACY GROUP CO., LTD. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20160303 Address after: 276017 Shandong Province, Linyi city Luozhuang District seven middle road on the west side Patentee after: Shandong Yu Xin pharmaceutcal corporation, Ltd Address before: Seven of 276017 Shandong province Linyi city Luozhuang District Patentee before: Shandong Luo Xin Pharmaceutical Group Plc |